SEC Company Response from Adicet Bio, Inc. (ACET) (CIK 0001720580) (ACET) — Feb 8, 2019
Adicet Bio, Inc. (ACET) (CIK 0001720580)
Date: Feb. 8, 2019 · CIK: 0001720580 · Accession: 0001193125-19-032297
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229499
Letter
resTORbio, Inc.
500 Boylston Street, 12th Floor
Boston, Massachusetts 02116
February 8,
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: resTORbio, Inc.: Registration Statement on Form S-3 filed February 1, 2019
(File No. 333-229499)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), resTORbio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to February 12, 2019, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Danielle Lauzon of Goodwin Procter LLP at (617) 570-1955.
Sincerely,
resTORbio, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP resTORbio, Inc. 500 Boylston Street, 12th Floor Boston, Massachusetts 02116 February 8, 2019 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: resTORbio, Inc.: Registration Statement on Form S-3 filed February 1, 2019 (File No. 333-229499) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), resTORbio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to February 12, 2019, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. If you have any questions regarding this request, please contact Danielle Lauzon of Goodwin Procter LLP at (617) 570-1955. Sincerely, resTORbio, Inc. /s/ Chen Schor Chen Schor President and Chief Executive Officer cc: John McCabe, resTORbio, Inc. Nancy Brennan, Esq., resTORbio, Inc. Mitchell S. Bloom, Esq., Goodwin Procter LLP Danielle Lauzon, Esq., Goodwin Procter LLP